Remove 2018 Remove Health Insurance Remove Prescription Drug Pricing
article thumbnail

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

Following the BLS report on the CPI for June 2024, PwC published their new annual report from PwC titled Behind the Numbers 2025 tells us that commercial health care spending is expected to grow some 8.0% for Individual health plans — increasing from 7.5% for Group plans and 7.5% and 7.0%, respectively.

Doctors 59
article thumbnail

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

Health Populi

Add into this picture a CCS Insight analyst’s forecast last week that Apple could enter the health insurance market in 2024. Consumers will be facing greater medical price inflation in 2023 for health insurance plans, based on the latest forecast from WTW.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

A second story involves a more mainstream drug: insulin, which is used by millions of people with diabetes. Research published in JAMA Internal Medicine in December 2018 found that as out-of-pocket costs for insulin have increased over the past few years, many patients use less insulin than needed. and 300,000 people worldwide.

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

prescriptions per person in 2018, two in three of which treated chronic conditions. the annual review of prescription drug supply, demand and Rx pricing dynamics from the IQVIA Institute for Human Data Science. prescription drug market might look like five years from now. Americans consumed 17.6

article thumbnail

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

This post updates my initial thoughts on the deal, given the morphing US healthcare market on both the traditional health services front and fast-evolving retail health environment. The nation’s largest retail pharmacy chain signed a deal to combine with one of the top three health insurance companies.

article thumbnail

The 2020 Social Determinants of Health: Connectivity, Art, Air and Love

Health Populi

As I pointed out in my 2020 Health Populi trendcast , the private sector is taking on more public health initiatives as policy progress at the Federal level feels frozen. Ironically, more social spending by the public sector could help address health outcomes for people, something for which we’ve had evidence for many years.

article thumbnail

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.